Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study

20235 citationsJournal Articlehybrid Open Access

Authors

Mario Luca Morieri · University of Padua

Itamar Raz · Hebrew University of Jerusalem

Agostino Consoli · University of Chieti-Pescara

Mauro Rigato · University of Padua

Annunziata Lapolla · University of Padua

Fabio Broglio · University of Turin

Enzo Bonora

Abstract

Elderly patients with T2D initiating dapagliflozin had a lower probability of achieving individualized HbA1c targets than those initiating DPP-4 inhibitors but displayed better improvements in extra-glycaemic endpoints.

Topics & Keywords

Diabetes Treatment and Management Pancreatic function and diabetes Metabolism, Diabetes, and Cancer

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Endocrinological Investigation

Volume 46, Issue 7, pp. 1429-1439

DOI: 10.1007/s40618-022-02002-2

Field-Weighted Citation Impact: 1.01